Takeda, Sanofi Genzyme, GSK, UCB Pharma, Teva Receive Reuters Events Awards for 2020
In December, Reuters held a virtual event in which they recognized companies from all over the industry for breakthroughs that will advance many areas of scientific inquiry.
Their headline sponsor for the event was Medullan, whose CEO Ahmed Albaiti, said, “We are a passionate team of people focused on innovation at the nexus of technology, medicine, and the human condition. We celebrate a human-centered culture that gives voice to patients and their care providers, so those programs can be held accountable to those voices and needs. We were absolutely delighted to support this year’s awards program, which recognized individuals and groups who are committed and relentlessly passionate about elevating patient voices, perspectives and needs into everything they do.”
You can see the full video of the presentations at the links provided. Here’s a summary:
Global Health Pioneer
Finalists: AstraZeneca, Takeda, Medicines 360, Novartis & PTC Therapeutics, Boehringer Ingelheim
Winner: Judith Kinley, Senior Scientific Director, Oncology, for Takeda’s R&D Capacity Building Program
Patient Champion Award: Pharma
Finalists: Novartis, Takeda & Genentech
Winner: Dr. Susanne Weissbäecker, Global Head of Access to Medicines, Takeda
Most Valuable Collaboration
Finalists: Takeda, Biogen, Servier, AstraZeneca, ACTO
Winner: Dr. Susanne Weissbäecker , Global Head of Access to Medicines, Takeda, for Bluepring for Innovative Healthcare Access
Patient Champion Award: Patient Advocate
Finalists: Mike Wenger of Trialscope; Jennifer McNary, Rare Disease Advocate; Lilly Stairs of Patient Authentic; Beverly Vote, Publisher of Breast Cancer Wellness Magazine; Keri Yale of Patient Affairs and Engagement
Winner: Mike Wenger, Trialscope
Most Promising Agile Transformation
Finalists: GSK, Pfizer, Novartis, Boehringer Ingelheim
Winners: Sonal Bhatia, VP, North America Medical Lead, Rare Disease, and Younos Abdulsattar, US Vyndagel Medical Team Lead, Pfizer, Use of AI/ML to Develop Approaches to Help Identify Patients at Risk for ATTR-CM
Most Valuable Education Initiative
Finalists: Sanofi Genzyme, PTC Therapeutics, BioDelivery Sciences, Pfizer, Astellas, Regeneron
Winner: Paul Rowe, VP, Head of Global Medical, Immunology, Sanofi Genzyme for the Advent Program
Most Valuable Awareness Initiative
Finalists: Merck Oncology, Horizon Therapeutics, Athenex Oncology and Astellas
Winner: Michelle Rivas, Senior Manager, Product Communications, Horizon Therapeutics, for #Rareis Uplifting the Rare Disease Community
Most Valuable Data and Insights Initiative
Finalists: AstraZeneca, Novartis, UCB
Winner: Anita Moser, Head of Analytics and Insights, UCB, for UCB Engages with Physicians to Meet Patients’ Needs Through Dynamic Targeting
Most Valuable Service or Digital Therapy
Finalists: EY, MediFind, Cecelia Health, GSK, PRA Health Sciences
Winner: Rachel Levin, Senior Global Multi-Channel Marketing Manager, GSK , for MyVaccinationHub
Entrepreneur Award: Patient Solution
Finalists: Annexus Health, One Three Biotech, Biolab Sciences, Chronically Simple, PRA Health Sciences
Winner: Bob Maguire, Founder, President & CEO, Biolab Sciences, for Re-Imagining Wound Care with the Patient’s Own DNA
Entrepreneur Award: Health Solution
Finalists: One Three Biotech, Annexus Health, Single Care, Biolab Sciences, BioSensics
Winner: Bradley Pryde, Co-founder and COO, One Three Biotech, for Re-Designing Drug Discovery Through Biology-Driven AI
Most Valuable Breakthrough/Discovery
Finalists: Theranica, Ionis, Horizon, Teva
Winner: Keven Gessner, Vice President Respiratory, Teva, for Program Digihaler
Most Valuable Healthcare/HCP Initiative
Finalists: GSK, Galderma, W2O Group
Winner: Paul O’Grady, Global Oncology Scientific Communications and Strategy Head, GSK, for Pivoting to Virtual Medical Education in Oncology During Covid-19